AstraZeneca Settles Row With Ranbaxy

AstraZeneca, UK’s second largest drug maker, on Tuesday announced an out-of -court settlement with Ranbaxy Laboratories on a pending patent infringement litigation on its heartburn drug esomeprazole. 
Business Standard